Related Experiment Videos
[Mortality risk factors for upper gastrointestinal bleeding at Brazzville university hospital]
Rody Stéphane Ngami1, Philestine Clausina Mikolele Ahoui Apendi1,2, Pétula Moulene2
1Service de Gastroentérologie et Médecine Interne, CHU de Brazzaville, 13, avenue Auxence Ickonga, Moungali, BP : 32.
In the absence of interventional endoscopy the treatment of upper digestive hemorrhage a the brazzaville university hospital is only medicinal. Objective of this work was to identify risk factors for upper gastrointestinal bleeding by conducting a retrospective case-type study conducted over a period of 2 years. The 180 patients included for upper digestive hemorrhage were divided into 2 groups accordind to their progressive modality : deceaded patients (cases) and non-deceased patients (controls). Risk factors for mortality were studied by logistic regression. The mortality linked to upper gastrointestinal bleedind was 36.6%, the risk factors for death were age between 30 and 60 with an OR of 9.79 ; male (OR of 2.03) ; late hospitalization over 24 hours (OR of 6.30) ; blood transfusions (OR of 3.5). The protective factors were hemoglobin greater 7 g/dL (OR of 0.28) ; treatment by proton pump inhibitors (OR of 0.36). In conclusion, reducing the still high mortalty rate in our country requires taking into account the identified risque factors and aquiring endoscopic hemostasis equipement.
In the absence of interventional endoscopy the treatment of upper digestive hemorrhage a the brazzaville university hospital is only medicinal. Objective of this work was to identify risk factors for upper gastrointestinal bleeding by conducting a retrospective case-type study conducted over a period of 2 years. The 180 patients included for upper digestive hemorrhage were divided into 2 groups accordind to their progressive modality : deceaded patients (cases) and non-deceased patients (controls). Risk factors for mortality were studied by logistic regression. The mortality linked to upper gastrointestinal bleedind was 36.6%, the risk factors for death were age between 30 and 60 with an OR of 9.79 ; male (OR of 2.03) ; late hospitalization over 24 hours (OR of 6.30) ; blood transfusions (OR of 3.5). The protective factors were hemoglobin greater 7 g/dL (OR of 0.28) ; treatment by proton pump inhibitors (OR of 0.36). In conclusion, reducing the still high mortalty rate in our country requires taking into account the identified risque factors and aquiring endoscopic hemostasis equipement.